The TriggerHappy Trial (Triggerhappy)

Sahlgrenska University Hospital

Status: Active, not recruiting

Conditions: Trigger Thumb; Minimally Invasive Surgery; Trigger Finger

Treatments: Procedure: Proximal phalangeal level; Drug: Volar to the MCP-joint

Study type: Interventional

Funder types: Other

Identifiers

NCT04568993

The TriggerHappy Trial

Details and patient eligibility

About

This is a prospective randomized multicenterstudy focusing on PROMs after primary corticoid injection for triggerfinger with a comparison of two different injection techniques.

Full description

This study aims to compare two different methods of corticosteroid injections in patients with triggerfinger, and to study the effects of these injections by day-to-day self-assessment by the included study persons for four weeks. The patient assess: 1. Pain 2. Motion and 3. Triggering by VAS scale every day for four weeks.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:•

1. Triggering of one or more fingers and/or impaired active finger motion and/or pain during active finger motion
2. Localized tenderness volar to the MCP joint of the affected finger
3. The patient seeks treatment

Exclusion Criteria:

1. Previous treatment for triggerfinger in the finger to be treated
2. Impaired function of finger due to previous trauma/infection or other condition
3. Suspicion of other cause than triggeriinger/tendovaginitis
4. Patient not able to follow instructions

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

proximal phalangeal level

Experimental group

Description:

injection in the the tendon sheet over proximal phalanx of finger

Treatment:

Procedure: Proximal phalangeal level

volar MCP level

Active Comparator group

Description:

injection above the A1 pulley volar to the MCP joint

Treatment:

Drug: Volar to the MCP-joint